SANUWAVE Health, Inc. (SNWV)
USD 30.41
(2.03%)
USD 30.41
(2.03%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.15 Million USD | -33.76% |
| 2022 | 21.36 Million USD | -3.62% |
| 2021 | 22.16 Million USD | 6.01% |
| 2020 | 20.91 Million USD | 125.22% |
| 2019 | 9.28 Million USD | 11.37% |
| 2018 | 8.33 Million USD | 92.93% |
| 2017 | 4.32 Million USD | 4.65% |
| 2016 | 4.12 Million USD | -20.87% |
| 2015 | 5.21 Million USD | -20.83% |
| 2014 | 6.59 Million USD | 0.07% |
| 2013 | 6.58 Million USD | -0.38% |
| 2012 | 6.61 Million USD | -29.29% |
| 2011 | 9.34 Million USD | -22.83% |
| 2010 | 12.11 Million USD | 33.36% |
| 2009 | 9.08 Million USD | 34557.61% |
| 2008 | 26.21 Thousand USD | -23.03% |
| 2007 | 34.05 Thousand USD | 156.28% |
| 2006 | 13.28 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.07 Million USD | 40.56% |
| 2024 Q2 | 3.06 Million USD | -39.49% |
| 2023 Q2 | 2.54 Million USD | -43.4% |
| 2023 FY | 14.15 Million USD | -33.76% |
| 2023 Q3 | 3.88 Million USD | 52.83% |
| 2023 Q4 | 3.6 Million USD | -7.16% |
| 2023 Q1 | 4.49 Million USD | -33.71% |
| 2022 FY | 21.36 Million USD | -3.62% |
| 2022 Q2 | 4.99 Million USD | 18.87% |
| 2022 Q1 | 4.19 Million USD | -20.78% |
| 2022 Q3 | 5.4 Million USD | 8.22% |
| 2022 Q4 | 6.77 Million USD | 25.46% |
| 2021 Q1 | 5.45 Million USD | -27.63% |
| 2021 FY | 22.16 Million USD | 6.01% |
| 2021 Q2 | 5.9 Million USD | 8.29% |
| 2021 Q3 | 5.5 Million USD | -6.81% |
| 2021 Q4 | 5.29 Million USD | -3.74% |
| 2020 Q3 | 7.18 Million USD | 115.86% |
| 2020 FY | 20.91 Million USD | 125.22% |
| 2020 Q1 | 2.85 Million USD | 4.65% |
| 2020 Q2 | 3.32 Million USD | 16.6% |
| 2020 Q4 | 7.53 Million USD | 4.88% |
| 2019 Q4 | 2.72 Million USD | 10.9% |
| 2019 FY | 9.28 Million USD | 11.37% |
| 2019 Q1 | 1.94 Million USD | 25.54% |
| 2019 Q2 | 2.15 Million USD | 10.6% |
| 2019 Q3 | 2.46 Million USD | 14.4% |
| 2018 Q1 | 1.3 Million USD | -11.11% |
| 2018 FY | 8.33 Million USD | 92.93% |
| 2018 Q4 | 1.54 Million USD | -49.75% |
| 2018 Q3 | 3.08 Million USD | 28.16% |
| 2018 Q2 | 2.4 Million USD | 85.0% |
| 2017 Q2 | 1.39 Million USD | 95.2% |
| 2017 FY | 4.32 Million USD | 4.65% |
| 2017 Q1 | 715.06 Thousand USD | -35.48% |
| 2017 Q4 | 1.46 Million USD | 95.6% |
| 2017 Q3 | 747.67 Thousand USD | -46.43% |
| 2016 Q4 | 1.1 Million USD | 11.88% |
| 2016 Q1 | 886.61 Thousand USD | -34.0% |
| 2016 Q3 | 990.57 Thousand USD | -13.38% |
| 2016 FY | 4.12 Million USD | -20.87% |
| 2016 Q2 | 1.14 Million USD | 28.98% |
| 2015 Q4 | 1.34 Million USD | -5.76% |
| 2015 Q1 | 1.27 Million USD | 17.74% |
| 2015 FY | 5.21 Million USD | -20.83% |
| 2015 Q3 | 1.42 Million USD | 21.73% |
| 2015 Q2 | 1.17 Million USD | -8.41% |
| 2014 Q1 | 2.14 Million USD | 49.52% |
| 2014 Q4 | 1.08 Million USD | -30.79% |
| 2014 Q3 | 1.56 Million USD | -12.33% |
| 2014 Q2 | 1.78 Million USD | -16.63% |
| 2014 FY | 6.59 Million USD | 0.07% |
| 2013 Q2 | 1.86 Million USD | 45.77% |
| 2013 Q3 | 2 Million USD | 7.82% |
| 2013 Q4 | 1.43 Million USD | -28.54% |
| 2013 FY | 6.58 Million USD | -0.38% |
| 2013 Q1 | 1.27 Million USD | -25.77% |
| 2012 Q1 | 1.92 Million USD | -24.64% |
| 2012 Q2 | 1.46 Million USD | -23.76% |
| 2012 Q3 | 1.49 Million USD | 2.29% |
| 2012 Q4 | 1.72 Million USD | 14.83% |
| 2012 FY | 6.61 Million USD | -29.29% |
| 2011 Q3 | 2.19 Million USD | -8.1% |
| 2011 Q4 | 2.55 Million USD | 16.27% |
| 2011 Q2 | 2.38 Million USD | 7.86% |
| 2011 FY | 9.34 Million USD | -22.83% |
| 2011 Q1 | 2.21 Million USD | -42.9% |
| 2010 Q3 | 2.62 Million USD | -1.12% |
| 2010 Q4 | 3.87 Million USD | 47.69% |
| 2010 FY | 12.11 Million USD | 33.36% |
| 2010 Q1 | 2.95 Million USD | 14.33% |
| 2010 Q2 | 2.65 Million USD | -10.15% |
| 2009 Q2 | 4886.00 USD | -6.67% |
| 2009 Q1 | 5235.00 USD | 121.17% |
| 2009 Q4 | 2.58 Million USD | -4.86% |
| 2009 FY | 9.08 Million USD | 34557.61% |
| 2009 Q3 | 2.71 Million USD | 55517.74% |
| 2008 FY | 26.21 Thousand USD | -23.03% |
| 2008 Q4 | 2367.00 USD | -67.43% |
| 2008 Q3 | 7267.00 USD | -50.84% |
| 2008 Q2 | 14.78 Thousand USD | 721.68% |
| 2008 Q1 | 1799.00 USD | -93.37% |
| 2007 FY | 34.05 Thousand USD | 156.28% |
| 2007 Q4 | 27.11 Thousand USD | 414.52% |
| 2007 Q2 | 1005.00 USD | 0.0% |
| 2007 Q3 | 5270.00 USD | 424.38% |
| 2006 FY | 13.28 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -1810.552% |
| IR-Med Inc. | 4.89 Million USD | -189.15% |
| Polarean Imaging plc | 12.24 Million USD | -15.59% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -971.643% |
| Avitar, Inc. | 3.56 Million USD | -296.441% |
| AVITA Medical, Inc. | 80.77 Million USD | 82.482% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -1912.945% |
| Össur hf. | 396.18 Million USD | 96.428% |
| Zecotek Photonics Inc. | 3.46 Million USD | -308.818% |
| QHSLab, Inc. | 961.65 Thousand USD | -1371.529% |
| Wellstar International, Inc. | 1.79 Million USD | -688.49% |
| Össur hf. | 396.18 Million USD | 96.428% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 35.022% |
| Escalon Medical Corp. | 5.25 Million USD | -169.509% |
| Aurora Spine Corporation | 8.65 Million USD | -63.454% |
| BrainsWay Ltd. | 28.01 Million USD | 49.493% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | -47.956% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 57.85% |
| Vivos Inc. | 2.78 Million USD | -407.73% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 98.65% |
| Kelyniam Global, Inc. | 2.27 Million USD | -521.955% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -1294.32% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -3149.369% |
| Nanomix Corporation | 8.36 Million USD | -69.114% |
| Theraclion SA | 7.43 Million USD | -90.206% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -993.098% |
| Positron Corporation | 1 Million USD | -1304.866% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -354.951% |
| Lombard Medical, Inc. | 30.29 Million USD | 53.282% |
| ALR Technologies Inc. | 6.33 Million USD | -123.343% |
| Stratec SE | 46.32 Million USD | 69.45% |
| Vycor Medical, Inc. | 1.27 Million USD | -1009.479% |
| Heart Tronics, Inc. | 14.46 Million USD | 2.137% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -11641.035% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -6755.474% |
| VMS Rehab Systems, Inc. | 63.63 USD | -22239409.665% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -305.125% |
| Ingen Technologies, Inc. | 1.88 Million USD | -651.825% |
| Odyssey Group International, Inc. | -14.26 Million USD | 199.228% |
| United American Healthcare Corporation | 59 Thousand USD | -23884.746% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -3372.766% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -2129.599% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -734.589% |
| Urologix, Inc. | 10.09 Million USD | -40.22% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -1020.132% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -137.9% |
| SS Innovations International, Inc. | 21.38 Million USD | 33.818% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -6046.169% |
| Smith & Nephew plc | 3.46 Billion USD | 99.592% |
| NIOX Group Plc | 22.27 Million USD | 36.479% |
| Fuse Medical, Inc. | 10.35 Million USD | -36.724% |
| Broncus Holding Corporation | 38.15 Million USD | 62.908% |
| Brain Scientific Inc. | 9.66 Million USD | -46.449% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -37.349% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -23213.783% |